Literature DB >> 20486085

[Diagnosis and treatment of pulmonary hypertension: European guidelines 2009].

M M Hoeper1, H A Ghofrani, M Gorenflo, E Grünig, D Schranz, S Rosenkranz.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20486085     DOI： 10.1055/s-0029-1244112

Source DB:  PubMed          Journal:  Pneumologie        ISSN： 0934-8387


× No keyword cloud information.
  4 in total

1.  Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension.

Authors:  Xiao-Wei Song; Lu-Lu Zou; Ling Cui; Song-Hua Li; Yong-Wen Qin; Xian-Xian Zhao; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  [Pulmonary arterial hypertension].

Authors:  F Reichenberger; R Voswinckel
Journal:  Internist (Berl)       Date:  2011-04       Impact factor: 0.743

3.  The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.

Authors:  C Reiss; I Mindukshev; V Bischoff; H Subramanian; L Kehrer; A Friebe; J-P Stasch; S Gambaryan; U Walter
Journal:  Br J Pharmacol       Date:  2015-10-18       Impact factor: 8.739

4.  Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension.

Authors:  Xiao-Dan Liu; Sheng-Yu Guo; Li-Li Yang; Xiao-Li Zhang; Wen-Yi Fu; Xiao-Fei Wang
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.